Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A3D4G4 / Name: Can-Fite BioPharma / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Can-Fite BioPharma Ltd. Stock

For the coming years our community has positive and negative things to say abot the Can-Fite BioPharma Ltd. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Can-Fite BioPharma Ltd. in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-02

Can-Fite Biopharma Ltd.'s financials at a first glance appear to raise concerns due to some negative trends observable in certain metrics. However, a deeper analysis is required to fully comprehend the financial health of the company and identify potential pros and cons.

Cash and Short-term Investments: On a positive note, Can-Fite Biopharma Ltd. has a notable amount of cash and short-term investments. As of the end of 2022, the company has $7,987,000 in cash and short-term investments. This strong cash position could be a major advantage when it comes to facing financial challenges or making strategic investments.

Net working capital: Another positive aspect of the company is its net working capital, which stands at $6,655,000. This highlights the company's ability to cover its short-term liabilities with its short-term assets, enhancing its financial stability.